Glucotrack today announced the results from the first-in-human clinical study of its long-term continuous blood glucose ...

Senseonics (NYSE:SENS) has offered some insight into its plans for its next-generation implantable continuous glucose ...

The biggest names in diabetes tech gathered in Chicago this past weekend for the American Diabetes Association's 85th ...

(Nasdaq:MODD) has shared new data highlighting the use of its insulin pump technology to deliver GLP-1 therapeutics.

(Nasdaq:GCTK) believes it can tap into a diabetes market that includes millions of people who aren't being served completely.

A future launch of the dual monitor would only bolster the company’s wide range of diabetes management options. In addition ...

“Inhaled insulin can quickly get to the carbohydrates that are in the bloodstream, get them into the cells and out of the ...

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

Additionally, Insulet shared that it has two planned clinical trials for new algorithms for its platforms. One involves ...

LifePlus announced the clinical validation of its non-invasive and cuffless wearable for continuous glucose and blood ...

BTIG analysts said today that Beta Bionics expects to launch a new insulin patch pump system in the U.S. by the end of 2027.